Clonazepam
Klonopin · Rivotril · 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2h-4-benzodiazepin-2-one · 5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one · RO4023 · Sentil · Landsen · Rivotri

Identifiers & Physical Properties
| CAS No. | 106955-87-7 |
|---|---|
| Molecular formula | C15H10ClN3O3 |
| Average molar mass | 315.71 g/mol |
| Monoisotopic mass | 315.0410689 g/mol |
| SMILES | O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 |
| InChIKey | DGBIGWXXNGSACT-UHFFFAOYSA-N |
| PubChem CID | 2802 |
| ChEMBL | CHEMBL452 |
| ChEBI | CHEBI:3756 |
| EC No. | 216-596-2 |
| DTXSID | DTXSID1022845 |
Chemical & Physical Properties
| XLogP | 2.4 |
|---|---|
| Topological polar surface area | 87.3 |
| Hydrogen bond donors | 1 |
| Hydrogen bond acceptors | 4 |
| Rotatable bonds | 1 |
| Heavy atoms | 22 |
| Formal charge | 0 |
| Complexity | 491 |
| LogP (partition coefficient) | 2.41log Kow = 2.412.7 |
| Odor | Faint odor |
| Color/Form | White crystals from ethanol-methylene chlorideOff-white to light yellow crystalline powder |
| Solubility | 100In water, <100 mg/L at 25 °CInsoluble in benzeneslightly soluble in acetone, methanol, chloroformSolubility in mg/mL at 25 °C: acetone 31chloroform 15methanol 8.6ether 0.7benzene 0.51.06e-02 g/LPractically insoluble in water, slightly soluble in alcohol and in methanol. |
| Decomposition | When heated to decomposition it emits very toxic fumes of /hydrogen chloride and nitrogen oxides/. |
| Melting point | 238-240237.5 °C236.5 - 238.5 °C236.5-238.50C |
| Physical Description | Solid |
| Stability/Shelf Life | The commercially available conventional tablets have an expiration date of 5 years following the date of manufacture.Stable under recommended storage conditions. |
| Dissociation Constants | pK1 = 1.5pK2 = 10.5 |
| Kovats Retention Index | 2803286028062833283228562878281328852857.12843.3282728142934.628532835.228632848.42879 |
| Collision Cross Section | 168.2 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)]171 Ų [M+H]+ [CCS Type: DTMethod: single field calibrated] |
| Boiling point | 524.5±50.0 °C(Predicted) |
| Density | 1.4592 (rough estimate) |
| Refractive index | 1.6470 (estimate) |
| Flash point | 11 °C |
| Storage conditions | 2-8°C |
| Physical state | powder |
| pKa (acidity coefficient) | 1.5, 10.5(at 25℃) |
| Color | light yellow |
| Henry's law constant | 1.4×107 mol/(m3Pa) at 25℃, HSDB (2015) |
| Major applications | pharmaceutical (small molecule) |
| InChI | 1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) |
| InChIKey | DGBIGWXXNGSACT-UHFFFAOYSA-N |
| SMILES | Clc1ccccc1C2=NCC(=O)Nc3ccc(cc23)N(=O)=O |
| CAS DataBase Reference | 1622-61-3(CAS DataBase Reference) |
| FDA UNII | 5PE9FDE8GB |
| NIST Chemistry Reference | Clonazepam(1622-61-3) |
| ATC code | N03AE01 |
| EPA Substance Registry System | 2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro- (1622-61-3) |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| Protein binding | 86% |
| Excreted unchanged in urine | <0.5% |
| Volume of distribution | 3(L/kg) |
| Biological half-life | 20-60 / - |
| GHS pictogram | GHS02,GHS06,GHS08 |
| Signal word | Danger |
| GHS hazard statements | H225-H301+H311+H331-H370 |
| GHS precautionary statements | P210-P260-P280-P301+P310-P311 |
| Target organs | Central nervous system |
| Hazard symbols | F,T |
| Risk statements (R) | 11-23/24/25-39/23/24/25 |
| Safety statements (S) | 7-16-36/37-45-24/25-22 |
| UN transport number | UN 1230 3/PG 2 |
| Water hazard class (WGK) | 2 |
| RTECS number | DF2100000 |
| Hazard class | 6.1(b)Aquatic Chronic 3STOT SE 3 |
| Packing group | III |
| Customs code | 2933910000 |
| Storage class | 11 - Combustible Solids |
| Hazardous substances data | 1622-61-3(Hazardous Substances Data) |
| Toxicity | LD50 orally in mice: >4000 mg/kg (Blum) |
Safety & Regulations
| GHS classification | This chemical does not meet GHS hazard criteria for 12.5% (1 of 8) of reports.DangerH336 (50%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposureNarcotic effects]H360 (12.5%): May damage fertility or the unborn child [Danger Reproductive toxicity]H361 (50%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]H362 (25%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]H412 (50%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]H413 (12.5%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]P203, P260, P261, P263, P264, P270, P271, P273, P280, P304+P340, P318, P319, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 8 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Reported as not meeting GHS hazard criteria per 1 of 8 reports by companies.There are 7 notifications provided by 7 of 8 reports by companies with hazard statement code(s).Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. |
|---|---|
| Regulatory information | DEA schedule IV controlled substanceClonazepam: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right. |
| Other safety information | IMAP assessments - 2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-: Environment tier I assessmentIMAP assessments - 2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-: Human health tier I assessment |
| FDA requirements | Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. ... Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: Clonazepam (DEA Code Number: 2737) is included on this list. |
Applications & Uses
Description
Clonazepam is a first-generation antiepileptic drug (AED) known under the proprietary brand name of Rivotril® (Roche, Basel) in the UK and Klonopin® (Roche, Basel) in the USA.
Description
Clonazepam (Item No. 14263) is an analytical reference material categorized as a benzodiazepine. Clonazepam is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.
Uses
Antiepileptic agent with anxiolytic and antimanic properties. Anticonvulsant. This is a controlled substance (depressant)
General Description
Clonazepam is useful in absence seizures and in myoclonicseizures. Tolerance to the anticonvulsant effect of the clonazepamoften developed rather quickly, and it is a commonproblem with the BZDs. Metabolism involves hydroxylationof the C-3 position, followed by glucuronidation andnitro group reduction, followed by acetylation.